New Aspects in Studies of Acne in Women

Cover Page

Abstract


The review generalizes and summarizes new information about epidemiology, pathogenesis, diagnostics and treatment of acne in women.

About the authors

A. V. Samtsov

Military Medical Academy named after S.M. Kirov Ministry of Defense of the Russian Federation Akademika

Author for correspondence.
Email: avsamtsov@mail.ru

Russian Federation

References

  1. Королев Ю.Ф. Материалы к клинике, этиологии, патогенезу и лечению себореи и ее осложнений: Автореф. дис. ... д-ра мед. наук. Л., 1961. 31 с. - в надзаг. : 1-й Ленинградский мед. ин-т
  2. Королев Ю.Ф. Себорея и угри. Минск: Беларусь 1972. 144 с. [Korolev Yu.F. Seboreya i ugri. Minsk: Belarus' 1972. 144 s.]
  3. Chen et al. Acne-associated syndromes: models for better understanding of acne pathogenesis JEADV; 2011; 25: 637-647.
  4. Dreno B., Layton A., Zouboulis C. et al. Adult female acne: a new paradigm. JEADV 2013; 27: 1063-1070.
  5. Preneau S., Dreno B. Female acne - a different subtype of teenager acne? JEADV 2012; 26: 277-282.
  6. Thiboutot D., Gollnick H., Bettoli V. et al. New insights into the management of acne: An update from the Global Alliance to Improve Outcomes in Acne Group. J Am Acad Dermatol, 2009; 60: S1-50.
  7. Nast A., Dreno B., Bettoli V. et al. European Evidence-based (S3) Guidelines for the Treatment of Acne. JEADV 2012, 26: 1-29.
  8. Перламутров Ю., Ольховская К.Б. Скинорен Гель в терапии и профилактике акне. Клин. дерматол. и венерол. 2007;4: 40-43.
  9. Gollnick H.P.M., Graupe K., Zaumseil R.P. Azelaic acid 15% gel in the treatment of acne vulgaris. Combined results of two double-blind clinical comparative studies. J Dtsch Dermatol Ges 2004; 2(10): 841-847.
  10. Graupe K., Cunliffe W.j., Gollnick H.P.M., et al. Efficacy and safety of topical azelaic acid (20 percent cream): an overview of results from European clinical trials and experimental reports. Cutis 1996; 57: 20-35.

Statistics

Views

Abstract - 151

PDF (Russian) - 130

Refbacks

  • There are currently no refbacks.

Copyright (c)



This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies